New York, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Nebulizer System Market, By Product Type, By Accessories, By Sales channel, By End Use, By ...

Dublin, Aug. 12, 2021 (GLOBE NEWSWIRE) -- The "Global Nebulizer System Market, By Product Type (Jet Nebulizer System, Mesh Nebulizer System, Ultrasonic Nebulizer System), By Accessories (Main ...

SUN-101 (glycopyrrolate) is a long-acting muscarinic antagonist (LAMA) bronchodilator delivered via the innovative, proprietary eFlow nebulizer closed system. Developed by PARI Pharma, eFlow is a ...

DUBLIN, Aug. 12, 2021 /PRNewswire/ -- The "Global Nebulizer System Market, By Product Type (Jet Nebulizer System, Mesh Nebulizer System, Ultrasonic Nebulizer System), By Accessories (Main Apparatus ...

Savara and PARI Granted a European Patent Covering the Drug-Device Combination of MOLBREEVI* Delivered Via the Proprietary eFlow® Nebulizer System Savara Inc. (Nasdaq: SVRA) (the Company), a clinical ...

NESS ZIONA, Israel--(BUSINESS WIRE)--Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company focused on orphan indications, reports that the Israeli Patent Office (ILPO) ...

Lonhala Magnair is available as a 25mcg strength inhalation solution per 1mL vial. Sunovion announced the launch of Lonhala Magnair (glycopyrrolate) inhalation solution for the long-term, maintenance ...

STARNBERG, Germany, June 7, 2016 /PRNewswire/ -- PARI Pharma, a company focused on the development of advanced aerosol therapies using eFlow Technology, announces that its proprietary closed eFlow ...

A nebulizer transforms medicine into a breathable mist. The person inhales the mist, allowing the body to absorb the medicine quickly and effectively. In this article, we look at the benefits and uses ...

LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced the European Patent Office (EPO) ...